An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Judith Falloon; Jing Yu; Mark T. Esser; Tonya Villafana; Yu Li

doi:10.1093/infdis/jix503

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Judith Falloon, Jing Yu, Mark T. Esser, Tonya Villafana, Yu Li, Filip Dubovsky, Therese Takas, Myron J. Levin, Ann R. Falsey

Oxford University Press (2017) • Volume 216, Issue 11, Pages 1362-1370

PDF Available

Abstract

NCT02508194.

Quick Actions

Read Full Paper

Publication Info

DOI

10.1093/infdis/jix503

Language

English

Topic

Respiratory viral infections research

Keywords

Medicine, Placebo, Immunology, Virus, Population, Adjuvant, Antibody, Vaccination, Respiratory system, Incidence (geometry), Virology, Internal medicine

Published

September 18, 2017

Citations

124 citations

FWCI

8.99

External Resources

DOI Link OpenAlex

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

Segment anything in medical images

Three-year outcomes of post-acute sequelae of COVID-19

CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress

Suggested Papers

Suggested Papers

Segment anything in medical images

Three-year outcomes of post-acute sequelae of COVID-19

CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress